UnknownNCT01127568
A Novel Treatment For Chronic PTSD (PTSD) Using Post-Reactivation Propranolol
Medication studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2010
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 50
- Sponsor
- Douglas Mental Health University Institute
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01127568
- Official title
Show the full official title
A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Douglas Mental Health University Institute, a university.
Does this study involve medication?
Yes. The study involves medication, including Propranolol is available in generic form as the Wyeth product under the trade name Inderal..
Who can participate?
Listed age limits: 18 years to 65 years.
